Great question — and it sounds like things are moving in a really positive direction with remission! Here's what's known about Rituximab as a maintenance therapy for follicular lymphoma (FL):
People treated with a combination of chemotherapy and Rituximab (like Bendamustine + Rituximab) tend to have longer remission Show Full Answer
Great question — and it sounds like things are moving in a really positive direction with remission! Here's what's known about Rituximab as a maintenance therapy for follicular lymphoma (FL):
People treated with a combination of chemotherapy and Rituximab (like Bendamustine + Rituximab) tend to have longer remission periods than those treated with chemotherapy alone. After achieving remission, Rituximab maintenance therapy is commonly used to help keep the lymphoma from coming back. Here's how it typically works:
- It's usually taken once every few months
- The course generally lasts up to two years
- The goal is to eliminate any remaining cancer cells and slow their return
This approach has been shown to extend remission periods for many people with follicular lymphoma. Advances in targeted therapies like Rituximab have contributed to significantly improved survival rates and longer remissions for people living with follicular lymphoma. A complete response to first-line treatment — which it sounds like was achieved — is a very encouraging sign for a longer-lasting remission.
Always check in with your oncologist about what outcomes to expect based on your specific situation, as individual factors like age and overall health also play a role.
2 days ago
Join
Your Privacy Choices
